ClinicalTrials.Veeva

Menu

Personalized Colonoscopy Preparation for Patients With Risk Factors for Inadequate Preparation

R

Rambam Health Care Campus

Status

Unknown

Conditions

Inadequate Preparation for Colonoscopy; Personalized Colonoscopy Preparation

Treatments

Drug: Sodium Picosulfate / Magnesium Oxide / Citric Acid in two split doses + one dose of polyethylene glycol + two Bisacodyl tablets day before the procedure

Study type

Interventional

Funder types

Other

Identifiers

NCT04033250
0117-19-RMB CTIL

Details and patient eligibility

About

Adequate bowel preparation is one of the most important quality measures in colonoscopy. Previous studies identified several factors associated with inadequate bowel preparation (IBP). No study has attempted to assign a different regimen to patients based on the presence of risk factors for inadequate bowel preparation.

The aim of the study is to check if a personalized bowel preparation regimen based on risk factors for IBP, will lead to an overall improvement in bowel preparation during colonoscopy.

Enrollment

600 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • previous IBP
  • concurrent medical conditions (e.g. diabetes, constipation)
  • medications (e.g. opioids and tricyclic antidepressants)

Exclusion criteria

  • previous colonic resection
  • patients with IBD
  • active CRC
  • chronic kidney disease at any stage
  • congestive heart failure at any stage
  • liver cirrhosis

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

600 participants in 3 patient groups

Interventional arm (group A)
Experimental group
Description:
Patients with risk factors for IBP who will receive "intensified" bowel preparation
Treatment:
Drug: Sodium Picosulfate / Magnesium Oxide / Citric Acid in two split doses + one dose of polyethylene glycol + two Bisacodyl tablets day before the procedure
Control arm (group B)
Active Comparator group
Description:
Patients with risk factors for IBP who will receive standard bowel preparation
Treatment:
Drug: Sodium Picosulfate / Magnesium Oxide / Citric Acid in two split doses + one dose of polyethylene glycol + two Bisacodyl tablets day before the procedure
Control arm (group c)
Active Comparator group
Description:
Patients without risk factors for IPB who will receive standard bowel preparation
Treatment:
Drug: Sodium Picosulfate / Magnesium Oxide / Citric Acid in two split doses + one dose of polyethylene glycol + two Bisacodyl tablets day before the procedure

Trial contacts and locations

1

Loading...

Central trial contact

Klein, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems